Neos Investment Management LLC Nurix Therapeutics, Inc. Transaction History
Neos Investment Management LLC
- $8.08 Trillion
- Q2 2025
A detailed history of Neos Investment Management LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Neos Investment Management LLC holds 81,112 shares of NRIX stock, worth $809,497. This represents 0.01% of its overall portfolio holdings.
Number of Shares
81,112
Previous 59,146
37.14%
Holding current value
$809,497
Previous $703 Million
31.48%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding NRIX
# of Institutions
174Shares Held
79.4MCall Options Held
126KPut Options Held
11.3K-
Black Rock Inc. New York, NY6.82MShares$68.1 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.06MShares$60.5 Million2.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.47MShares$44.6 Million0.0% of portfolio
-
Commodore Capital LP New York, NY3.95MShares$39.4 Million4.19% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$38.7 Million0.45% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $471M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...